Forte Biosciences Inc. (FBRX)
NASDAQ: FBRX
· Real-Time Price · USD
11.85
1.03 (9.52%)
At close: Aug 15, 2025, 3:59 PM
11.61
-2.03%
After-hours: Aug 15, 2025, 04:53 PM EDT
Forte Biosciences Ratios and Metrics
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
PE Ratio | -1.41 | -5.07 | -0.31 | -0.5 | -0.93 | -1.27 | -0.63 | -0.62 | -0.8 | -1.08 | -1.5 | -1.57 | -2.06 | -2.36 | -1.36 | -19.67 | -23.64 |
PEG Ratio | 0.03 | 0.15 | 0.01 | -0.01 | -0.05 | 0.03 | 0.02 | -0.02 | -0.02 | -0.04 | 0.12 | -0.09 | 0.09 | 0.04 | -0.05 | -1.1 | -14.43 |
PS Ratio | n/a | n/a | n/a | n/a | n/a | 4.98K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 2.30 | 2.77 | 1.10 | 1.49 | 0.96 | 0.85 | 0.62 | 0.88 | 0.64 | 0.54 | 0.47 | 0.50 | 0.54 | 0.76 | 0.97 | 9.16 | 8.30 |
P/FCF Ratio | -8.49 | -14.46 | -1.27 | -4.24 | -4.12 | -3.32 | -2.75 | -4 | -4.08 | -7.26 | -10.44 | -13.94 | -10.91 | -8.97 | -8.22 | -116.13 | -112.7 |
P/OCF Ratio | -8.54 | -14.51 | -1.27 | -4.24 | -4.12 | -3.33 | -2.77 | -4 | -4.08 | -7.26 | -10.44 | -13.94 | -10.91 | -8.81 | -8.22 | -116.13 | -112.7 |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | -1.49K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Quick Ratio | 5.22 | 6.76 | 2.06 | 2.82 | 9.45 | 10.45 | 6.30 | 4.88 | 9.65 | 13.06 | 19.45 | 25.67 | 32.17 | 24.19 | 12.45 | 17.42 | 23.57 |
Current Ratio | 5.22 | 6.76 | 2.06 | 2.82 | 9.45 | 10.45 | 6.30 | 4.88 | 9.65 | 13.06 | 19.45 | 25.67 | 32.17 | 24.19 | 12.45 | 17.42 | 23.57 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | 0.00 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | n/a | n/a | n/a | n/a | -62.56 | n/a | n/a | n/a | -823.17 | n/a | -201.33 | -47.43 | -78.55 | n/a | n/a | n/a |
Return on Equity | -0.41 | -0.14 | -0.9 | -0.74 | -0.26 | -0.17 | -0.25 | -0.36 | -0.2 | -0.13 | -0.08 | -0.08 | -0.07 | -0.08 | -0.18 | -0.12 | -0.09 |
Return on Assets | -0.33 | -0.12 | -0.47 | -0.48 | -0.23 | -0.15 | -0.21 | -0.29 | -0.18 | -0.12 | -0.07 | -0.08 | -0.06 | -0.08 | -0.16 | -0.11 | -0.08 |
Return on Invested Capital | -0.42 | -0.14 | -0.92 | -0.76 | -0.27 | -0.18 | -0.25 | -0.36 | -0.2 | -0.13 | -0.08 | -0.08 | -0.06 | -0.08 | -0.18 | -0.12 | -0.09 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | -978.67 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | -978.67 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | -1.06K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | -1.06K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |